Trial
NCT06188507
A First Time in Human Study to Evaluate the Safety and Tolerability of GSK3996401 Following Dosing With GSK4347859 in Healthy Participants
Phase ISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
GlaxoSmithKline
Collaborators
—
Condition
Systemic Lupus Erythematosus
Intervention
GSK4347859
Why stopped
The trial was temporarily halted due to findings in new non-clinical studies necessitating further investigation.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-10-03